Sorbent Therapeutics, Inc

📍 Sunnyvale, United States🗓 Founded 2005👥 6 employees💰 Last funded 2006
Sorbent Therapeutics is a private biopharmaceutical company focused on the development of adaptable non-absorbed polymeric drugs to satisfy unmet clinical needs in large markets such as Congestive Heart Failure (CHF), Chronic Kidney Disease (CKD), End Stage Renal Disease (ESRD), and Hypertension. The array of customized compounds under development in our pipeline are all based on CLP's robust platform, which can be tailored to sequester or contribute targeted ions and/or fluid.
1
Total investors
1
Early stage
0
Mid stage
0
Late stage
2005
Founded

Investors

1 investors
All
Early stage
Mid stage
Late stage
Investor geography1 country
United States
1
Frequently asked questions
Who invested in Sorbent Therapeutics, Inc?
Sorbent Therapeutics, Inc has 1 investors on record on gritt.io, including 1 early-stage backers.
When did Sorbent Therapeutics, Inc last raise funding?
The most recent investment in Sorbent Therapeutics, Inc recorded on gritt.io was in 2006.
When was Sorbent Therapeutics, Inc founded?
Sorbent Therapeutics, Inc was founded in 2005.
What industry is Sorbent Therapeutics, Inc in?
Sorbent Therapeutics, Inc operates in Pharmaceutical Manufacturing. Find similar Pharmaceutical Manufacturing investors on gritt.io.
Where is Sorbent Therapeutics, Inc based?
Sorbent Therapeutics, Inc is headquartered in Sunnyvale, United States.